No Data
No Data
Femasys Expands Global Patent Portfolio To Support Innovative Women's Health Solutions
Express News | Femasys Inc: Expects Resulting Patent, When Issued, Will Have an Anticipated Expiration in 2044 at Earliest
Express News | Femasys Announces Notice of Allowance for New U.S. Patent Application Covering Use of Femaseed® for Female Infertility Treatment
Femasys Announces Notice of Allowance for New U.S. Patent Application Covering Use of FemaSeed for Female Infertility Treatment
Femasys's Strategic Partnerships and Market Expansion Drive Buy Rating
Femasys Announces Partnership With HRC Fertility